David M. Knott Jr’s Xeris Biopharma Holdings XERS Stock Holding History

David M. Knott Jr’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.4M	Hold	1,060,000	–	–	4.44%	4
2026 Q1	$6.15M	Buy	1,060,000 +90,000	+9%	+$597K	3.66%	6
2025 Q4	$7.61M	Sell	970,000 -45,000	-4%	-$354K	3.53%	5
2025 Q3	$8.26M	Sell	1,015,000 -45,000	-4%	-$299K	3.33%	6
2025 Q2	$4.95M	Sell	1,060,000 -50,000	-5%	-$229K	2.24%	7
2025 Q1	$6.09M	Buy	1,110,000 +110,000	+11%	+$444K	2.88%	7
2024 Q4	$3.39M	Hold	1,000,000	–	–	1.23%	15
2024 Q3	$2.85M	Buy	1,000,000 +180,000	+22%	+$462K	1%	22
2024 Q2	$1.84M	Buy	820,000 +220,000	+37%	+$443K	0.74%	29
2024 Q1	$1.33M	Buy	600,000 +212,090	+55%	+$549K	0.47%	37
2023 Q4	$912K	Buy	+387,910	New	+$716K	0.35%	34

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

David M. Knott Jr's XERS Position: Q2 2026 in Review

David M. Knott Jr held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 1,060,000 shares worth $8.4M. The position accounts for 4.44% of the portfolio, ranked #4.

David M. Knott Jr first reported a position in XERS in Q4 2023 and has held it in 11 quarters since. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

David M. Knott Jr held 1,060,000 shares of Xeris Biopharma Holdings worth $8.4M as of Q2 2026.
David M. Knott Jr left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
Xeris Biopharma Holdings made up 4.44% of David M. Knott Jr's portfolio in Q2 2026, its #4 holding.
David M. Knott Jr first reported a position in Xeris Biopharma Holdings in Q4 2023 and has held it in 11 quarters since.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.